Presented by

Dr. Stephen Pennington

In moving to an era of precision medicine and healthcare it is pertinent to ask how proteomics can contribute to the development of new molecular diagnostics? Clearly, there is a huge opportunity to improve on current clinical tests for the diagnosis, prognosis and monitoring of disease.Drawing on examples of significant unmet clinical needs in prostate cancer and psoriatic arthritis this talk will seek to highlight how some of these opportunities may be addressed. In particular, some of key issues faced in the development of multiplexed protein assays and strategies for the delivery and implementation of these assays in a diagnostic setting will be discussed.